Lotus Pharmaceuticals, Inc. (OTCPK: LTUS)
Health Care · Pharmaceuticals · US
$0.00
+26.67% today · -40.2% 1Y
Lotus Pharmaceuticals, Inc. (OTCPK: LTUS) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $10.05M and employs 233 people.
Over the last twelve months the share price has lost 40.2%, trading between 0.00 and 0.01.
Tweenvest scores Lotus Pharmaceuticals, Inc. across four factors: quality 0/100, value 68/100. Its strongest factor is value.
LTUS price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $10.05M
- Revenue (TTM)
- $71.39M
- P/E
- 0.06
- EPS
- 0.06
- Dividend yield
- —
- Beta (5Y)
- -1.55
- 52-week high
- $0.01
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 2.64B
- Employees
- 233
- Next earnings
- —
About Lotus Pharmaceuticals, Inc.
Lotus Pharmaceuticals, Inc. currently has no substantial business activities. Headquartered in Nashville, Tennessee, the company previously focused on the development, production, and distribution of pharmaceutical products within the People's Republic of China.
- ISIN
- US5457152032
- Listed since
- Aug 9, 2005
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,231.78 | -0.15% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $272.81 | -0.12% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $155.85 | -0.38% |
| Roche Holding AGSWX: ROP | $371.62B | CHF371.90 | -0.51% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £123.29 | -1.18% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.51 | -0.21% |
Figures last refreshed Aug 18, 2026.